144 results
8-K
EX-4.2
OGEN
Oragenics Inc
1 Mar 24
Oragenics Announces Closing of Public Offering
4:05pm
be greater than the rights of our common stock. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, redemption … stock or adversely affect the rights and powers, including voting rights, of the holders of shares of common stock without any further vote or action
8-K
EX-1.1
OGEN
Oragenics Inc
1 Mar 24
Oragenics Announces Closing of Public Offering
4:05pm
.
Section 6. Miscellaneous.
a) No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends
8-K
EX-4.1
OGEN
Oragenics Inc
1 Mar 24
Oragenics Announces Closing of Public Offering
4:05pm
. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set
424B5
n5k098yi
29 Feb 24
Prospectus supplement for primary offering
4:41pm
424B5
gdc7d8oxbbtlt hbpy4b
27 Feb 24
Prospectus supplement for primary offering
5:04pm
8-K
xmkelk
16 Jan 24
Other Events
9:10am
424B5
wydgbvayl6y1wusx
16 Jan 24
Prospectus supplement for primary offering
9:04am
8-K
cx24q ajj3
8 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:00pm
8-K
EX-3.1
h8cgo46rbvgun 7x8s6
8 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:00pm
8-K
EX-2.1
rgm64wj64ul
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
9ti wtq0f
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
787sblb9
7 Aug 23
Oragenics, Inc. Announces Private Placement
8:09am
8-K
EX-99.1
pf11iz gbutl67
7 Aug 23
Oragenics, Inc. Announces Private Placement
8:09am
8-K
EX-3.1
0sj4k5vaomtxf mva9y
7 Aug 23
Oragenics, Inc. Announces Private Placement
8:09am